Résumé
La forte prévalence de cancers du sein et de l’ovaire (tableau I) chez les femmes porteuses d’une mutation BRCA1/2 justifie une prise en charge particulière.
This is a preview of subscription content, log in via an institution.
Preview
Unable to display preview. Download preview PDF.
Références
Chen S, Parmigiani G (2007) Meta-analysis of BRCA1 and BRCA2 penetrance. J Clin Oncol 25: 1329–1333
Institut National du Cancer (2009) Recommandations professionnelles: Chirurgie prophylactique des cancers avec prédisposition génétique. Cancer du sein/Cancer de l’ovaire www.e-cancer.fr
Rebbeck TR, Kauff ND, Domchek SM (2009) Meta-analysis of risk reduction estimates associated with risk-reducing salpingo-oophorectomy in BRCA1 or BRCA2 mutation carriers. JNCI 101: 80–87
Pujol P, Lasset C, Berthet P et al. (2012) Uptake of a randomized breast cancer prevention trial comparing letrozole to placebo in BRCA1/2 mutations carriers: the LIBER trial. Fam Cancer 11: 77–84
Kurian AW, Munoz DF, Rust P et al. (2012) Online Tool to Guide Decisions for BRCA1/2 Mutation Carriers. J Clin Oncol 30: 497–506
Rebbeck TR, Friebel T, Wagner T et al. (2005) Effect of short-term hormone replacement therapy on breast cancer risk reduction after bilateral prophylactic oophorectomy in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group. J Clin Oncol 23: 7804–7810
Iodice S, Barile M, Rotmensz N et al. (2010) Oral contraceptive use and breast or ovaran cancer risk in BRCA1/2 carriers: a meta-analysis. Eur J Cancer 46: 2275–2284
Kotsopoulos J, Librach CL, Lubinski J et al. (2008) Infertility, treatment of infertility, and the risk of breast cancer among women with BRCA1 and BRCA2 mutations: a case-control study. Cancer Causes Control 19: 1111–1119
Pauw AD, Stoppa-Lyonnet D, Andrieu N, Asselain B (2009) Estimation of individual breast cancer risk: relevance and limits of risk estimation models. Bull Cancer 96: 979–988
Cohen M, Jacquemier J, Maestro C et al. (2011) Femmes à risque. Oncologie 13: 618–614
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer-Verlag France, Paris
About this paper
Cite this paper
Rousset-Jablonski, C., This, P., Dagousset, I., de la Rochefordière, A., Noguès, C., Stoppa-Lyonnet, D. (2013). Pour une bonne prise en charge des patientes à risque familial de cancer du sein (actualités en oncogénétique). In: Acquis et limites en sénologie / Assets and limits in breast diseases. Springer, Paris. https://doi.org/10.1007/978-2-8178-0396-8_32
Download citation
DOI: https://doi.org/10.1007/978-2-8178-0396-8_32
Publisher Name: Springer, Paris
Print ISBN: 978-2-8178-0395-1
Online ISBN: 978-2-8178-0396-8